Reset with Lynlee
About
Take a step back, refocus, and Reset with Lynlee. Airing weekdays from 1pm to 4pm, the show brings clarity to the stories shaping Singapore and the world — from current affairs and global developments to business trends and industry shifts. Through insightful conversations and fresh perspectives, Lynlee explores what’s driving the headlines and where things are heading next. Featuring segments like Viewpoint, Industry Insight and Suite Talk, Reset goes beyond the noise to offer thoughtful analysis, real-world context and ideas that help you recalibrate for the rest of your day.
JAN 26, 2022
26/01/22 - Market View: SPACs, 26 JanOn Market View, Claressa Monteiro is joined by Candace Li, Market Analyst at the SGX, as they take a look at how the two SPACs companies are doing one week since its launch and get more information about what the SPAC space means to local investors.
|
|
|
|
17:21
|
JAN 25, 2022
25/01/22 - Soul of Business: The Business of Raising Money for CharityOn Soul of Business, Singaporeans gave in record sums to charity through online donation platforms last year. Into 2022, charities in Singapore will be looking to plan activities for the year ahead. Claressa Monteiro speaks to Prof. Sonja Prokopec, Associate Director Center of Excellence in Luxury, Arts, and Culture APAC, ESSEC Business School,totalk about the business of raising money for charity.
|
|
|
|
|
16:44
|
JAN 25, 2022
25/01/22 - Market View, 25 JanOn Market View, Claressa Monteiro is joined by Sani Hamid, Director for Wealth Management, Financial Alliance, as they deep dive into MAS's latest announcement to 'raise slightly' rate of appreciation of policy band to counter rising inflation, the reason behind Asian shares taking a tumble today, what to look out for upcoming flash PMIs this week, the Reits sector, revenge buying and investor sentiments.
|
|
|
|
|
16:53
|
JAN 24, 2022
24/01/22 - Market View, 24 JanOn Market View, Claressa Monteiro is joined by Geoff Howie, Market Strategist at the SGX as they break down the numbers of the just released CPI of Singapore, the STI, the trio of local banks' performance, Reits's earning reports, who's leading the markets in the region as well as the key focus of the Federal Open Market Committee meeting this week.
|
|
|
|
|
18:24
|
JAN 21, 2022
21/01/22 - Inspect A Gadget: Unusual SmartwatchesOn Inspect A Gadget, Claressa Monteirois joined by Christopher Lim, Digital Editor, The Business Times, as they look at some of the unusual smartwatches for different needs.
|
|
|
|
|
17:56
|
JAN 21, 2022
21/01/22 - Market View Wrap, 21 JanOn Market View, Claressa Monteiro is joined by Geoff Howie, Market Strategist at the SGX as they review the week's market movements - namely SPACs Vertex and Pegasus kicked off their trading on the SGX, factors on why the STI index is nearing 3,300, but not quite yet, commodities performance on the SGX plus a chock-a-block of reports coming out next week, including REITs.
|
|
|
|
|
19:22
|
JAN 20, 2022
20/01/22 - Market View, Australian Economy Outlook 2022On Market View, Claressa Monteiro is joined by Kyle Rodda, Analyst at IG, as they unpack the numbers and trends for the Australian economy in 2022 , with focus on ASX, property prices, trade spat with China, global supply chain disruptions as well as the upcoming CPI to be released next week.
|
|
|
|
|
16:13
|
JAN 20, 2022
20/01/22 - Chasing Cars : Hyundai TucsonOn Chasing Cars, Claressa Monteiro is joined by Julian Kho, Editor, SgCarMart, as they continue their review of the car of the week : this week, it’s the Hyundai Tucson, SgCarMart’s Most Improved winner.
|
|
|
|
|
19:42
|
JAN 19, 2022
19/01/22 - Soul of Business:On the Soul of Business, Claressa Monteiro speaks to Dr Jennifer Bourland, Head of Innovation Domain Cell & Tissue Systems, Evonik and Dr. Massimo Alberti, CEO and Founder, Revivo, on their partnership to develop organ-on-a-chip technology that will revolutionise chemical testing and drug development.
|
|
|
|
|
15:26
|
JAN 19, 2022
19/01/22 - Health Suites: Treating Covid-19On Health Suites, AstraZeneca has signed a new purchase agreement with the government of Singapore to deliver Evusheld, its long-acting antibody (LAAB) combination candidate, for the treatment of COVID-19. With the supply expected to arrive in Singapore by year end, Claressa Monteiro speaks to Vinod Narayanan, Country President, AstraZeneca Singapore, to find out more about Evusheld.
|
|
|
|
|
12:45
|
